
Loading, please wait...

Loading, please wait...

Recent breakthroughs in artificial intelligence show that GPT-5 could revolutionize AI esophageal cancer staging by matching the diagnostic accuracy of human specialists. Accurate staging for esophageal squamous cell carcinoma traditionally relies on the complex interpretation of F-fluorodeoxyglucose positron emission tomography (F-FDG-PET) images. However, significant workforce shortages in radiology and surgery often delay these critical reports. Consequently, researchers have turned to large language models (LLMs) to automate and accelerate this high-stakes diagnostic process.
A retrospective study at Tohoku University Hospital evaluated the performance of six LLMs against four blinded human evaluators. The results demonstrated that GPT-5 achieved a patient-level diagnostic accuracy of 85.8%, which statistically matched the 85.0% accuracy of a nuclear medicine specialist. Furthermore, GPT-5 significantly outperformed radiology residents and previous model iterations like GPT-4 Turbo. This indicates that advanced models can handle complex visual-medical tasks with high precision. Specifically, the model assessed lymph node metastases and distant metastases using standardized maximum-intensity projection (MIP) images.
Moreover, the researchers utilized the Matthews Correlation Coefficient to ensure robust performance metrics despite potential class imbalances in the dataset. GPT-5 recorded an MCC of 0.704, suggesting a strong correlation between the model's predictions and the reference standard radiology reports. Similarly, the study highlighted the benefits of zero-shot model analysis, which requires no task-specific training. Therefore, these findings suggest that LLMs could soon serve as reliable automated support systems in oncology centers. Nevertheless, clinicians must continue to verify AI outputs against local guidelines to ensure patient safety.
In countries like India, where esophageal cancer remains a major health challenge, such automated tools could alleviate the burden on tertiary care centers. For instance, many patients in rural areas present with advanced-stage disease, necessitating rapid and accurate staging for immediate intervention. Additionally, integrating AI into the workflow could help standardize reporting across different hospital levels. Although human oversight remains mandatory, the ability of GPT-5 to match specialist-level interpretation offers a promising solution to diagnostic delays.
While GPT-5 demonstrates accuracy comparable to nuclear medicine specialists, it is currently designed as a decision-support tool. Specialists should still review AI-generated staging to ensure clinical context and patient safety.
The model analyzes frontal maximum-intensity projection (MIP) images from FDG-PET scans. It evaluates these along with tumor location data to determine clinical N and M stages.
GPT-5 significantly outperforms GPT-4 Turbo and earlier versions in diagnostic accuracy and Matthews Correlation Coefficient. This progress reflects improved medical reasoning and better processing of medical imaging data.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Maruyama H et al. Evaluation of GPT-5 for Esophageal Cancer Staging Using Fluorodeoxyglucose Positron Emission Tomography Maximum-Intensity Projection Images: Comparative Pilot Study. JMIR Cancer. 2026 Feb 23. doi: 10.2196/86630. PMID: 41729569.
Talukdar B, Sharma B. Epidemiological Trends and Clinical Characteristics of Esophageal Cancer in North-East India: A Hospital-Based Descriptive Study from a Tertiary Cancer Center. Journal of Advances in Medicine and Medical Research. 2025 Nov 27.
Bhayana R et al. Large Language Models in Cancer Imaging: Applications and Future Perspectives. PMC. 2025 May 08.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comparative study shows GPT-5 matches specialist accuracy in staging esophageal cancer using PET images, potentially alleviating diagnostic burdens....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today